BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26399488)

  • 1. Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer.
    Abe T; Shirai K; Saitoh J; Ebara T; Shimada H; Tashiro M; Okano N; Ohno T; Nakano T
    Acta Oncol; 2016; 55(2):163-6. PubMed ID: 26399488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
    Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
    Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
    Pettersson N; Nyman J; Johansson KA
    Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer.
    Miura H; Inoue T; Shiomi H; Oh RJ
    J Radiat Res; 2015 Mar; 56(2):332-7. PubMed ID: 25504640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.
    Taremi M; Hope A; Lindsay P; Dahele M; Fung S; Purdie TG; Jaffray D; Dawson L; Bezjak A
    Radiat Oncol; 2012 Sep; 7():159. PubMed ID: 22985910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibility of chest wall dose reduction using volumetric-modulated arc therapy (VMAT) in radiation-induced rib fracture cases: comparison with stereotactic body radiation therapy (SBRT).
    Murakami Y; Nakano M; Yoshida M; Hirashima H; Nakamura F; Fukunaga J; Hirose TA; Yoshioka Y; Oguchi M; Hirata H
    J Radiat Res; 2018 May; 59(3):327-332. PubMed ID: 29800456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
    Park Y; Kim HJ; Chang AR
    Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
    Kita N; Tomita N; Takaoka T; Matsuura A; Okazaki D; Niwa M; Torii A; Takano S; Mekata Y; Niimi A; Hiwatashi A
    Clin Transl Radiat Oncol; 2023 Nov; 43():100683. PubMed ID: 37790583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-effect analysis of radiation induced rib fractures after thoracic SBRT.
    Stam B; van der Bijl E; Peulen H; Rossi MMG; Belderbos JSA; Sonke JJ
    Radiother Oncol; 2017 May; 123(2):176-181. PubMed ID: 28110960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late chest wall toxicity after MammoSite breast brachytherapy.
    Brashears JH; Dragun AE; Jenrette JM
    Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivered dose-effect analysis of radiation induced rib fractures after thoracic SBRT.
    Juan-Cruz C; Stam B; Belderbos J; Sonke JJ
    Radiother Oncol; 2021 Sep; 162():18-25. PubMed ID: 34166718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
    Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
    Shirai K; Kawashima M; Saitoh JI; Abe T; Fukata K; Shigeta Y; Irie D; Shiba S; Okano N; Ohno T; Nakano T
    PLoS One; 2017; 12(4):e0175589. PubMed ID: 28399182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosemetric Parameters Predictive of Rib Fractures after Proton Beam Therapy for Early-Stage Lung Cancer.
    Ishikawa Y; Nakamura T; Kato T; Kadoya N; Suzuki M; Azami Y; Hareyama M; Kikuchi Y; Jingu K
    Tohoku J Exp Med; 2016 Apr; 238(4):339-45. PubMed ID: 27087118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors.
    Nambu A; Onishi H; Aoki S; Tominaga L; Kuriyama K; Araya M; Saito R; Maehata Y; Komiyama T; Marino K; Koshiishi T; Sawada E; Araki T
    BMC Cancer; 2013 Feb; 13():68. PubMed ID: 23391264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
    Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.